Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Wines

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Journal of Virology|July 7, 2021
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected CellsSai Priya Anand, Shilei Ding, William D Tolbert, et al.
Nature Communications|July 19, 2022
Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in childrenJo-Anne Chan, Jessica R Loughland, Lauren de la Parte, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Journal of Virology|July 7, 2021
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected CellsSai Priya Anand, Shilei Ding, William D Tolbert, et al.
Nature Communications|July 19, 2022
Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in childrenJo-Anne Chan, Jessica R Loughland, Lauren de la Parte, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
Pageof 9